Rare Disease Designation and Global Prevalence Estimates: Defining the IgG4-Related Disease Market Size
The accurate determination of the IgG4-Related Disease (IgG4-RD) Market Size is a complex exercise, owing to its status as a relatively newly recognized systemic disease and its variable global prevalence rates. Although considered a rare disease in many Western regions, the true addressable market size is determined by the combination of its growing diagnosed prevalence and the high cost...
0 Reacties 0 aandelen 78 Views 0 voorbeeld